Doğrulanmiş Hiv Pozitif Olgularda Hepatit Virüsler ve Torch Grubu Mikroorganizmaların Serolojik Profillerinin İncelenmesi
Yükleniyor...
Tarih
2020 Mart
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Selçuk Üniversitesi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç: HIV virüsü, immün sistem yetmezliğine neden olarak, virüs, mantar ve protozoon kaynaklı enfeksiyonlara yakalanma riskini arttırmaktadır. Bu çalışmada; HIV pozitif hastalarda, Hepatitvirüsler (Hepatit A, Hepatit B ve Hepatit C) ve TORCH grubu
(Toxoplasma gondii, Rubella, Sitomegalovirüs (CMV), Herpes Simplex Virüs (HSV)) mikroorganizmaların serolojik profillerinin
belirlenmesi amaçlanmıştır.
Gereç ve Yöntem: 2017-2018 yıllarında Selçuk Üniversitesi Tıp Fakültesi Hastanesi’ne başvuran HIV şüpheli olgular (n:75) retrospektif
olarak incelenmiştir. Anti-HIV testi istemi olan serumlardan Architect i1000sr (Abbott Diagnostics, Almanya) cihazıyla "HIV1/2Ag/Ab Combo" testi çalışılmıştır. Pozitif serum örnekleri doğrulama için Türkiye Halk Sağlığı Kurumu Referans Laboratuvarı’na
gönderilmiştir. Doğrulanmış pozitif serum örnekleri olan hastalar, laboratuvarımızda HIV-RNA testi ile takip edilmiştir.
Bulgular: HIV pozitif hasta serumlarının 53’ünde Anti-HCV çalışılmış ve sadece birinde (%1.9) pozitif saptanmıştır. Anti-HAV IgG
ise 26 örneğin 16’sında (%61.5) pozitif olarak saptanmıştır. Toxoplasma IgG (n:49), RubellaIgG (n:35), RubellaIgM (n:21), CMV IgG
(n:40) ve HSV2 IgG (n:33)sırasıyla;%20.4, %97.1,%4.8,%92.5 ve%10 pozitif bulunmuştur.
Sonuç: Çalışılan hasta grubunda akut enfeksiyon göstergelerinden sadece Rubella IgM (%4.8) pozitif bulunmuştur, zamanla farklı
enfeksiyonların da gelişebileceği düşünülmektedir. Günümüzde artan HIV sıklığı göz önüne alındığında, hastaların bu konuda daha
fazla bilgilendirilmesi ve HIV pozitif hastaların serolojik profillerinin araştırılması büyük önem taşımaktadır
Objective: HIV virus increases the risk of infections caused by viruses, fungi and protozoa by causing immune system insufficiency. The aim of this study was to determine the frequency of hepatitis viruses (Hepatitis A, Hepatitis B and Hepatitis C) and TORCH group (Toxoplasmagondii, Rubella, Cytomegalovirus (CMV), Herpes SimplexVirus (HSV) microorganisms’ serologic profiles in HIV positive patients. Material and Methods: HIV suspected patients (n:75) that admitted to Selcuk University Medical Faculty Hospital between 2017-2018 were examined retrospectively. "HIV-1 / 2Ag / Ab Combo" tests have been studied with the Architect i1000sr (Abbott Diagnostics, Germany) device from the sera that have requested anti-HIV test. Positive serum samples were sent to the Public Health Authority Reference Laboratory for verification. Patients wih confirmed positive serum sampleswerefollowedby HIV-RNA test in ourlaboratory. Results: Anti-HCV was studied in 53 of the HIV positive patient sera and was positive in only one (1.9%).Anti-HAV IgG was positive in 16 (61.5%) of 26 samples.Toxoplasma IgG (n:49),RubellaIgG(n:35), RubellaIgM(n:21), CMV IgG(n:40)and HSV 2 IgG(n:33)were found positive; 20.4%, 97.1%, 4.8%, 92.5% and 10% respectively. Conclusion: Only Rubella IgM (4.8%) was found to be positive for acute infection in the study group. It is thought that different infections may develop in time. Considering the increasing frequency of HIV, it is necessary to inform the public more about this issue and to investigate the serologic profiles in HIV positive patients.
Objective: HIV virus increases the risk of infections caused by viruses, fungi and protozoa by causing immune system insufficiency. The aim of this study was to determine the frequency of hepatitis viruses (Hepatitis A, Hepatitis B and Hepatitis C) and TORCH group (Toxoplasmagondii, Rubella, Cytomegalovirus (CMV), Herpes SimplexVirus (HSV) microorganisms’ serologic profiles in HIV positive patients. Material and Methods: HIV suspected patients (n:75) that admitted to Selcuk University Medical Faculty Hospital between 2017-2018 were examined retrospectively. "HIV-1 / 2Ag / Ab Combo" tests have been studied with the Architect i1000sr (Abbott Diagnostics, Germany) device from the sera that have requested anti-HIV test. Positive serum samples were sent to the Public Health Authority Reference Laboratory for verification. Patients wih confirmed positive serum sampleswerefollowedby HIV-RNA test in ourlaboratory. Results: Anti-HCV was studied in 53 of the HIV positive patient sera and was positive in only one (1.9%).Anti-HAV IgG was positive in 16 (61.5%) of 26 samples.Toxoplasma IgG (n:49),RubellaIgG(n:35), RubellaIgM(n:21), CMV IgG(n:40)and HSV 2 IgG(n:33)were found positive; 20.4%, 97.1%, 4.8%, 92.5% and 10% respectively. Conclusion: Only Rubella IgM (4.8%) was found to be positive for acute infection in the study group. It is thought that different infections may develop in time. Considering the increasing frequency of HIV, it is necessary to inform the public more about this issue and to investigate the serologic profiles in HIV positive patients.
Açıklama
Anahtar Kelimeler
HIV, hepatit, seroloji, TORCH, Hepatitis, Serology
Kaynak
Selçuk Genel Tıp Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
30
Sayı
1
Künye
Maçin, S., Arslan, U., Fındık, D., (2020). Doğrulanmış Hiv Pozitif Olgularda Hepatit Virüsler ve Torch Grubu Mikroorganizmaların Serolojik Profillerinin İncelenmesi. Selçuk Genel Tıp Dergisi, 30(1), 48-52.
